Larson Financial Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.4K | Hold |
4,000
| – | – | ﹤0.01% | 1210 |
|
|
2025
Q1 | $31.3K | Hold |
4,000
| – | – | ﹤0.01% | 1193 |
|
|
2024
Q4 | $42K | Hold |
4,000
| – | – | ﹤0.01% | 952 |
|
|
2024
Q3 | $52.5K | Hold |
4,000
| – | – | ﹤0.01% | 887 |
|
|
2024
Q2 | $56.2K | Hold |
4,000
| – | – | ﹤0.01% | 778 |
|
|
2024
Q1 | $67.6K | Hold |
4,000
| – | – | 0.01% | 622 |
|
|
2023
Q4 | $56.5K | Hold |
4,000
| – | – | ﹤0.01% | 619 |
|
|
2023
Q3 | $41.2K | Hold |
4,000
| – | – | ﹤0.01% | 664 |
|
|
2023
Q2 | $65.9K | Hold |
4,000
| – | – | 0.01% | 496 |
|
|
2023
Q1 | $36.6K | Hold |
4,000
| – | – | ﹤0.01% | 611 |
|
|
2022
Q4 | $28.6K | Hold |
4,000
| – | – | ﹤0.01% | 623 |
|
|
2022
Q3 | $20K | Hold |
4,000
| – | – | ﹤0.01% | 629 |
|
|
2022
Q2 | $10K | Hold |
4,000
| – | – | ﹤0.01% | 714 |
|
|
2022
Q1 | $27K | Hold |
4,000
| – | – | ﹤0.01% | 475 |
|
|
2021
Q4 | $32K | Hold |
4,000
| – | – | 0.01% | 459 |
|
|
2021
Q3 | $39K | Hold |
4,000
| – | – | 0.01% | 340 |
|
|
2021
Q2 | $27K | Hold |
4,000
| – | – | 0.01% | 384 |
|
|
2021
Q1 | $36K | Hold |
4,000
| – | – | 0.01% | 304 |
|
|
2020
Q4 | $27K | Hold |
4,000
| – | – | 0.01% | 307 |
|
|
2020
Q3 | $20K | Hold |
4,000
| – | – | 0.01% | 319 |
|
|
2020
Q2 | $32K | Hold |
4,000
| – | – | 0.02% | 231 |
|
|
2020
Q1 | $32K | Hold |
4,000
| – | – | 0.02% | 183 |
|
|
2019
Q4 | $30K | Hold |
4,000
| – | – | 0.02% | 186 |
|
|
2019
Q3 | $17K | Buy |
+4,000
| New | +$17K | 0.01% | 236 |
|